Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
Purpose: Approximately 30% of patients with major depressive disorder (MDD) are treatment resistant. There is an unquestionable need for new treatment strategies. Subanesthetic doses of intravenous (IV) ketamine have a rapid antidepressant effect in treatment-resistant depression (TRD). This paper d...
Saved in:
Main Authors: | Maria Gałuszko-Wȩgielnik, Adam Włodarczyk, Wiesław Jerzy Cubała, Alina Wilkowska, Natalia Górska, Jakub Słupski |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/32bae4a593b64cee95bf4471b5209d28 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
by: Wilkowska A, et al.
Published: (2021) -
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
by: Szarmach J, et al.
Published: (2020) -
Ketamine in Bipolar Disorder: A Review
by: Wilkowska A, et al.
Published: (2020) -
Clozapine As Transformative Treatment In Bipolar Patients
by: Wilkowska A, et al.
Published: (2019) -
Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
by: Michael Colla, et al.
Published: (2021)